CEO: Robert Azelby

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Alder BioPharmaceuticals Inc is a biotechnology company. It is engaged in the discovery, development, and commercialization of therapeutic antibodies addresses diseases with limited medical options. The company operates across the U.S and Australia.


Key numbers

Market Capitalization:
Shares Outstanding: 0
Float:
Next Earning Date:
TTm EPS:
TTm Dividend Rate:
200 days moving average:12.71
50 days moving average: 14.4
One day percent Change: 0



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,